ASCO 2009 - A Multicenter Phase II Study of Cisplatin, Gemcitabine, and Bevacizumab as First-Line Chemotherapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU-0475 - Session Highlights

Last Updated ( Wed, 03 June 2009 )

Login to read more...

ASCO 2009 - Randomized Trial of p53 Targeted Adjuvant Therapy for Patients with Organ-Confined Node-Negative Urothelial Bladder Cancer - Session Highlights

Last Updated ( Wed, 03 June 2009 )

Login to read more...

ASCO 2009 - A Single Institution Experience with Induction and Maintenance Intravesical Docetaxel in the Management of Non-Muscle-Invasive Bladder Cancer Refractory to BCG Therapy - Session Highlights

Last Updated ( Tue, 02 June 2009 )

Login to read more...

ASCO 2009 - Ethnic Differences in Bladder Cancer Survival - Session Highlights

Last Updated ( Tue, 02 June 2009 )

Login to read more...

ASCO 2009 - Prognostic Risk Group Classification for Patients with Platinum-Refractory Metastatic Urothelial Cancer Treated with Second-Line Chemotherapy - Session Highlights

Last Updated ( Tue, 02 June 2009 )

Login to read more...

ASCO 2009 - Adjuvant Chemotherapy for High-Risk Upper Tract Urothelial Carcinoma: Results from the Upper Tract Urothelial Carcinoma Collaboration - Session Highlights

Last Updated ( Tue, 02 June 2009 )

Login to read more...

ASCO 2009 - Vascular Thromboembolic Events in Patients with Advanced Urothelial Cancer Treated with Carboplatin/Gemcitabine Alone or in Combination with Bevacizumab - Session Highlights

Last Updated ( Tue, 02 June 2009 )

Login to read more...

ASCO 2009 - A Phase II Study of Sunitinib on a Continuous Dosing Schedule in Patients with Relapsed or Refractory Urothelial Carcinoma - Session Highlights

Last Updated ( Tue, 02 June 2009 )

Login to read more...